Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (6,434,800)	$ (1,783,966)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	2,811,065	757,545
Amortization of debt issuance costs	208,543	83,647
Stock based compensation expense related to issuance of restricted stock	4,842
Accretion of preferred equity costs	15,848
Unrealized foreign currency adjustment	468,154	(149,278)
Changes in operating assets and liabilities:
Other assets, net	(18,324)	(208,781)
Accounts payable and accrued liabilities	(439,667)	498,532
Due to affiliates	1,727,150	89,354
Net cash used in operating activities	(1,657,189)	(712,947)
Cash flows from investing activities:
Purchase of real estate facilities	(51,910,735)	(39,241,028)
Additions to real estate facilities	(919,043)	(108,099)
Investments in unconsolidated real estate ventures	(2,264,568)	(177,946)
Net cash used in investing activities	(55,094,346)	(39,527,073)
Cash flows from financing activities:
Proceeds from issuance of secured debt	33,677,500
Scheduled principal payments of secured debt	(122,018)
Prepaid debt issuance costs	(36,770)
Debt issuance costs	(88,319)
Gross proceeds from issuance of common stock	11,006,130	52,344,661
Offering costs	(1,086,148)	(4,584,234)
Proceeds from issuance of preferred equity in our Operating Partnership	15,000,000
Preferred equity issuance costs	(189,920)
Distributions paid to common stockholders	(1,396,733)	(404,558)
Distributions paid to noncontrolling interest in our Operating Partnership	(84,089)	(67,845)
Distributions paid to preferred unitholders in our Operating Partnership	(87,500)
Net cash provided by financing activities	56,592,133	47,288,024
Impact of foreign exchange rate changes on cash and restricted cash	(683,798)
Net change in cash, cash equivalents and restricted cash	(843,200)	7,048,004
Cash, cash equivalents and restricted cash, beginning of period	7,791,544	4,580,759
Cash, cash equivalents and restricted cash, end of period	6,948,344	11,628,763
Supplemental disclosures and non-cash transactions:
Cash paid for interest	2,249,913	369,541
Real estate facilities in due to affiliates	2,198,424	1,200,000
Investments in unconsolidated real estate ventures in due to affiliates	382,819
Debt issuance costs in due to affiliates	150,000
Debt issuance costs in accounts payable and accrued liabilities	10,888
Proceeds from issuance of common stock in accounts payable and accrued liabilities	(120,000)	(85,000)
Offering costs included in accounts payable and accrued liabilities	216,738	263,795
Interest rate swap contract in accounts payable and accrued expenses	31,489
Foreign currency translation adjustment	437,759
Issuance of shares pursuant to distribution reinvestment plan	974,931	268,630
Distributions payable to common stockholders	857,816	421,192
Distributions payable to noncontrolling interests in our Operating Partnership	28,964	$ 23,365
Real estate and construction in process in accounts payable and accrued liabilities	4,529
Deposits applied to acquisition of real estate	220,000
Distributions payable to Preferred unitholders	$ 90,417